65,437 trials
Diabetes Mellitus
Primary: Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 26. — 0.01; -0.38; -0.52 mg/dL — p=<0.001
Parkinson Disease
Primary: Percentage of Patients With Adverse Events, Adverse Drug Reactions, Serious Adverse Events — 84.5; 76.2; 45.7; 23.1 Percentage of participants
Diabetes Mellitus
Primary: Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 26. — -0.61; -0.59; -0.10 percentage of Glycosylated Hemoglobin — p=<0.001
ADHD
Primary: Area Under the Steady-state Plasma Concentration-time Curve (AUC 0-t) for Methylphenidate Hydrochloride (MPH) Using Two Different Formulations (Equasym XL and Metadate…
Tracheitis · Tracheobronchitis · Bronchitis
Primary: Compliance (Was the Dosage Followed - Yes, no) — 3154; 12; 15; 2 Participants
Bronchiolitis Obliterans Syndrome · Graft Rejection · Lymphocytic Bronchiolitis
Primary: Prevalence of Bronchiolitis Obliterans Syndrome (BOS) — 5; 19 participants
Smoking Cessation
Primary: Percentage of Fully Compliant Participants — 0 percentage of participants
Acne Vulgaris
Primary: Skin Dryness Score — 0.15; 0.46; 0.14; 0.29 Units on a scale
Breast Cancer
Primary: Mean Score on Cosmetic Outcome Visual Analog Scale (VAS) — 45.4; 67.2 score on scale
Vasculitis · Wegener's Granulomatosis · Microscopic Polyangiitis
Primary: Disease Remission — 63; 52 Participants — p=<0.001
Attention Deficit/Hyperactivity Disorder(ADHD)
Primary: Participants Experiencing Collisions During "Surprise Events" in Driving Simulator — 8; 17 participants
Acute Lymphoblastic Leukemia
Primary: Number of Participants With Complete Remission — 41 Participants
Primary Hypercholesterolemia
Primary: Percent Change in Low-Density Lipoprotein - Cholesterol (LDL-C) Values — -25.8; -15.1; 0.8 Percent change — p=<0.0001
Tracheitis · Tracheobronchitis · Bronchitis
Primary: Disappearance or Significant Alleviation of Symptoms — 3109 Participants
Hemophilia B
Primary: Annualized Number of Bleeding Episodes — 35.1; 4.6; 2.6 episodes — p=<0.0001